Fundamental dimension Equity attribute | CCLXPeer $0.018▲+12.50% Cap $17.99MP/E -0.3x QuantScore36/100 | AMCXLeader $9.18▼-1.61% Cap $297.8MP/E -19.5x QuantScore44/100 | BBOPPeer $1.000.00% Cap $8.73MP/E — QuantScore31/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
31/100 |
31/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 80/100 | — |
Health Piotroski, Altman Z, leverage & liquidity | 25/100 | 22/100 | — |
Growth Revenue / earnings growth & margins | 0/100 | 35/100 | — |
Sentiment Analyst ratings, targets & revisions | — | 50/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.3x | -19.5x | — |
Forward P/E (next FY) | — | 7.9x | — |
EV / EBITDA (TTM) | -285.2x | 1.4x | — |
Price / Sales | — | 0.1x | — |
Price / Free Cash Flow | -5497.6x | 1.6x | — |
PEG ratio | 0.00 | 0.12 | — |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 1 / 9 | 5 / 9 | — |
Altman Z-Score | -9712.74 (Distress) | 1.79 (Distress) | — |
Total debt / equity | 0.00 | 1.92 | — |
Quick ratio | 0.0x | 1.8x | — |
Interest coverage | — | 1.0x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | -4.5% | — |
Net income growth YoY | -28.0% | +139.5% | — |
Gross margin (TTM) | 0.0% | 48.3% | — |
Operating margin (FY) | — | 11.1% | — |
FCF margin (FY) | — | 11.8% | — |
5. Trailing price performancePrice change over period |
1M return | +80.0% | -23.5% | -50.0% |
3M return | -42.1% | -6.2% | 0.0% |
6M return | +3500.0% | +4.8% | 0.0% |
Year to date | +3500.0% | -3.6% | 0.0% |
1Y return | +3500.0% | +20.3% | -20.0% |
3Y return | +3500.0% | -21.5% | 0.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.0004 -98.0% premium | $225.31 +2354.3% upside | — — |
Wall Street consensus target | — — | $13.50 +47.1% · range $10.00–$23.00 | — — |
Consensus stance | — | 24% Buy56% Hold20% Sell | — |